This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: The Cleveland Clinic Foundation, University of Illinois, Dystrogen Therapeutics Corporation. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shaker Heights, OH (US) (2017)
- Chicago, IL (US) (2017 - 2021)
Company Filing History:
2 out of 1,075 
2 out of 2,437 
1 out of 1 Years Active: 2017-2025
Title: Maria Siemionow: Pioneering Innovator in Cell Therapy
Introduction
Maria Siemionow is a distinguished inventor based in Chicago, IL (US). She has made significant contributions to the field of cell therapy, particularly in the areas of transplantation and treatment of immune deficiencies and genetic disorders. With a total of 5 patents to her name, Siemionow's work has the potential to transform medical practices and improve patient outcomes.
Latest Patents
Among her latest patents is the invention of a multi-chimeric cell and therapy for transplantation and treatment of immune deficiencies and genetic disorders. This innovative approach involves creating a multi-chimeric cell through the ex vivo fusion of three or more hematopoietic stem cells, mesenchymal stem cells, myoblasts, pericytes, or satellite cells from different donors. The application of these cells in transplant therapy is groundbreaking. Another notable patent is related to myoblast chimeric cells (MCCs). This invention focuses on methods and compositions for generating and utilizing MCCs to treat muscle diseases, such as muscular dystrophy. The MCCs consist of a myoblast derived from a patient with muscle disease and a myoblast from a healthy donor.
Career Highlights
Maria Siemionow has had a remarkable career, working with prestigious institutions such as the Cleveland Clinic Foundation and the University of Illinois. Her expertise and dedication to advancing medical science have earned her recognition in the field of regenerative medicine.
Collaborations
Throughout her career, Siemionow has collaborated with various professionals, including her coworker Krzysztof Siemionow. These partnerships have facilitated the development of innovative therapies and have contributed to her success as an inventor.
Conclusion
Maria Siemionow's contributions to cell therapy and regenerative medicine are invaluable. Her innovative patents and collaborative efforts continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile